SULLIVAN CHRISTOPHER RYAN (Interim CFO) sold 64.6% of their position (72.72K shares) of AVALO THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.45M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+37.95K
Price / share
$9.88
Trade value
$374.90K
% of position
Common Stock
Shares
+2.88K
Price / share
$9.88
Trade value
$28.41K
% of position
Common Stock
Shares
−37.95K
Price / share
$19.85
Trade value
$753.33K
% of position
Common Stock
Shares
−3.75K
Price / share
$19.94
Trade value
$74.76K
% of position
Common Stock
Shares
+31.03K
Price / share
$9.88
Trade value
$306.59K
% of position
Common Stock
Shares
−31.03K
Price / share
$20.05
Trade value
$622.32K
% of position
Net shares
−873.00
Net value
-$740.52K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/17/2026 | M · Option Exercise | +37.95K | $9.88 | $374.90K | 93.1% | 40.77K | 78.72K |
| Common Stock Direct | 8/17/2026 | M · Option Exercise | +2.88K | $9.88 | $28.41K | 3.7% | 78.72K | 81.59K |
| Common Stock Direct | 8/17/2026 | S · Sale | −37.95K | $19.85 | $753.33K | 46.5% | 81.59K | 43.65K |
| Common Stock Direct | 8/17/2026 | S · Sale | −3.75K | $19.94 | $74.76K | 8.6% | 43.65K | 39.90K |
| Common Stock Direct | 8/18/2026 | M · Option Exercise | +31.03K | $9.88 | $306.59K | 77.8% | 39.90K | 70.93K |
| Common Stock Direct | 8/18/2026 | S · Sale | −31.03K | $20.05 | $622.32K | 43.7% | 70.93K | 39.90K |
| Total | −873.00 | -$740.52K | ||||||
Stock Option (Right to Buy)
Common Stock
37.95K shares
Shares
−37.95K
Strike price
9.88
Held after
130.15K
Exercisable
—
Stock Option (Right to Buy)
Common Stock
2.88K shares
Shares
−2.88K
Strike price
9.88
Held after
127.27K
Exercisable
—
Stock Option (Right to Buy)
Common Stock
31.03K shares
Shares
−31.03K
Strike price
9.88
Held after
96.24K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock37.95K shares | 8/17/2026 | M · Option Exercise | −37.95K | 9.88 | — | 130.15K |
| Stock Option (Right to Buy) Direct | Common Stock2.88K shares | 8/17/2026 | M · Option Exercise | −2.88K | 9.88 | — | 127.27K |
| Stock Option (Right to Buy) Direct | Common Stock31.03K shares | 8/18/2026 | M · Option Exercise | −31.03K | 9.88 | — | 96.24K |